XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 17 January 2019
Asset Under Management 251.32 Million (USD)
1 Month Total Return 2.83 %
Year To Date Return 8.85 %
1 Year Total Return -11.84 %
3 Year Annualized Total Return -2.91 %
NAV 39.89
Share Outstanding 6,300,270
Top 10 Holdings (16 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
NEKTAR THERAPEUTICS NKTR EQUI 0.0558104600
ELI LILLY & CO LLY EQUI 0.0476548000
MALLINCKRODT PLC MNK EQUI 0.0475923300
ALLERGAN PLC AGN EQUI 0.0471037700
MYLAN NV MYL EQUI 0.0459971200
MERCK & CO. INC. MRK EQUI 0.0445495800
JOHNSON & JOHNSON JNJ EQUI 0.0439644600
PFIZER INC PFE EQUI 0.0439035300
ENDO INTERNATIONAL PLC ENDP EQUI 0.0432899100
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0430468700